A novel variant in plakophilin-2 gene detected in a family with arrhythmogenic right ventricular cardiomyopathy.

Mutations with pathogenic potential in proteins located in or at the composite junctions of the intercalated disk connecting mammalian cardiomyocytes: a reference thesaurus for arrhythmogenic cardiomyopathies and for Naxos and Carvajal diseases. Cell Tissue Res (2012) 0.88

Arrhythmogenic right ventricular cardiomyopathy. Lancet (2009) 4.46

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13

Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol (2008) 3.42

Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation (2007) 2.56

Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res (2009) 2.48

Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol (2011) 2.31

Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation (2004) 2.23

Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet (2009) 2.19

Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol (2007) 1.86

Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J Am Coll Cardiol (2010) 1.73

A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat (2009) 1.38

Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc Pathol (2006) 1.22

Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations. Clin Res Cardiol (2009) 1.20

Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon? Curr Opin Cardiol (2007) 1.01

Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol (2007) 0.97

Left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy - a scintigraphic and echocardiographic study. Clin Physiol Funct Imaging (2005) 0.95

Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Clin Genet (2009) 0.90

Missense variants in plakophilin-2 in arrhythmogenic right ventricular cardiomyopathy patients--disease-causing or innocent bystanders? Cardiology (2009) 0.90

Arrhythmogenic right ventricular cardiomyopathy: an update. Heart (2009) 0.89

Desmoplakin disease in arrhythmogenic right ventricular cardiomyopathy: early genotype-phenotype studies. Eur Heart J (2005) 0.85

Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace (2007) 0.83

Arrhythmogenic right ventricular dysplasia presenting with ventricular tachycardia in a father and son. Clin Cardiol (1987) 0.82

Late potentials and ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol (1999) 0.81

Signal-averaged electrocardiographic parameter progression as a marker of increased electrical instability in two cases with an overt form of arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol (2002) 0.77

Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy. J Electrocardiol (2000) 0.75

Toward early diagnosis in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Interv Card Electrophysiol (2009) 0.75

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J (2015) 3.70

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol (2003) 3.55

ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation (2003) 2.68

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace (2015) 2.66

Forensic casework analysis using the HVI/HVII mtDNA linear array assay. J Forensic Sci (2005) 1.53

Current practice of ventricular tachycardia ablation in patients with implantable cardioverter-defibrillators. Europace (2012) 1.52

Genetic identification of putative remains of the famous astronomer Nicolaus Copernicus. Proc Natl Acad Sci U S A (2009) 1.50

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace (2012) 1.46

Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation. Europace (2013) 1.41

The role of premature atrial contractions as the main triggers of postoperative atrial fibrillation. J Electrocardiol (2005) 1.40

2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Rev Esp Cardiol (Engl Ed) (2016) 1.39

Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Hum Mol Genet (2008) 1.13

Epicardial off-pump pulmonary vein isolation and vagal denervation improve long-term outcome and quality of life in patients with atrial fibrillation. J Thorac Cardiovasc Surg (2009) 1.04

The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J (2009) 1.02

Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey. Europace (2012) 0.98

Practices of cardiac implantable electronic device follow-up: results of the European Heart Rhythm Association survey. Europace (2012) 0.94

Long-term effects of the maze procedure on atrial size and mechanical function. Ann Thorac Surg (2008) 0.93

Real-time DNA quantification of nuclear and mitochondrial DNA in forensic analysis. Biotechniques (2002) 0.91

How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey. Europace (2012) 0.90

Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study. Europace (2013) 0.90

Acute and clinical effects of cryoballoon pulmonary vein isolation in patients with symptomatic paroxysmal and persistent atrial fibrillation. Europace (2008) 0.90

Current practice for diagnosis and management of silent atrial fibrillation: results of the European Heart Rhythm Association survey. Europace (2013) 0.89

A DNA microarray system for forensic SNP analysis. Forensic Sci Int (2004) 0.87

Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace (2015) 0.86

Forensic mitochondrial coding region analysis for increased discrimination using pyrosequencing technology. Forensic Sci Int Genet (2006) 0.86

Forensic analysis of autosomal STR markers using Pyrosequencing. Forensic Sci Int Genet (2009) 0.85

Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation. Europace (2012) 0.85

Effect of right atrial overdrive pacing in the prevention of symptomatic paroxysmal atrial fibrillation: a multicenter randomized study, the PAF-PACE study. Pacing Clin Electrophysiol (2003) 0.85

Novel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals. BMC Cancer (2008) 0.84

Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey. Europace (2012) 0.83

Atrial size and transport function after the Maze III procedure for paroxysmal atrial fibrillation. Ann Thorac Surg (2002) 0.83

Diagnosis and management of patients with inherited arrhythmia syndromes in Europe: results of the European Heart Rhythm Association Survey. Europace (2014) 0.83

Analysis of the putative remains of a European patron saint--St. Birgitta. PLoS One (2010) 0.83

Relationship between intracardiac impedance and left ventricular contractility in patients undergoing cardiac resynchronization therapy. Europace (2011) 0.83

A high quality of life is maintained late after Maze III surgery for atrial fibrillation. Eur J Cardiothorac Surg (2009) 0.82

Current periprocedural management of ablation for atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Europace (2014) 0.82

Complete discrimination of six individuals based on high-resolution melting of hypervariable regions I and II of the mitochondrial genome. Biotechniques (2009) 0.82

Surgical and hybrid atrial fibrillation ablation procedures. Europace (2012) 0.82

Monitoring in the management of atrial fibrillation. Europace (2012) 0.81

Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. Europace (2015) 0.81

Automated genotyping of biobank samples by multiplex amplification of insertion/deletion polymorphisms. PLoS One (2012) 0.81

Approach to cardiac resyncronization therapy. Europace (2012) 0.80

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Europace (2013) 0.80

Atrial function after left atrial epicardial cryoablation for atrial fibrillation in patients undergoing mitral valve surgery. J Interv Card Electrophysiol (2011) 0.80

Evaluation of mitochondrial DNA coding region assays for increased discrimination in forensic analysis. Forensic Sci Int Genet (2007) 0.80

ELECTRa (European Lead Extraction ConTRolled) Registry--shedding light on transvenous lead extraction real-world practice in Europe. Herzschrittmacherther Elektrophysiol (2013) 0.80

Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). Europace (2015) 0.80

CardioPulse Articles. Eur Heart J (2015) 0.79

Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Europace (2013) 0.79

Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey. Europace (2014) 0.79

[Guidelines for cardiac pacing and cardiac resynchronization therapy]. Rev Port Cardiol (2008) 0.78

Autonomic denervation after the Maze procedure. Pacing Clin Electrophysiol (2003) 0.78

Preference for oral anticoagulation therapy for patients with atrial fibrillation in Europe in different clinical situations: results of the European Heart Rhythm Association Survey. Europace (2015) 0.78

Atrial fibrillation ablation techniques. Europace (2012) 0.77

Active site mutants of Drosophila melanogaster multisubstrate deoxyribonucleoside kinase. Eur J Biochem (2003) 0.77

Mitochondrial DNA analysis of Swedish population samples. Int J Legal Med (2013) 0.77

European clinical experience with a dual chamber single pass sensing and pacing defibrillation lead. Pacing Clin Electrophysiol (2002) 0.77

Rapid quantification and sex determination of forensic evidence materials. J Forensic Sci (2003) 0.76

[Guidelines in cardiac pacing and resynchronization therapy]. Kardiol Pol (2007) 0.75

An analysis of the alleged skeletal remains of Carin Göring. PLoS One (2012) 0.75

[Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease]. Rev Esp Cardiol (2004) 0.75

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology]. G Ital Cardiol (Rome) (2016) 0.75

[Let the defence have access to forensic expertise, too]. Lakartidningen (2012) 0.75

Stroke and bleeding risk evaluation in atrial fibrillation: results of the European heart rhythm association survey. Europace (2014) 0.75

Imaging techniques in electrophysiology and implantable device procedures: results of the European Heart Rhythm Association survey. Europace (2013) 0.75

Forensic Analysis of Mitochondrial and Autosomal Markers Using Pyrosequencing®. Methods Mol Biol (2015) 0.75

[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. Kardiol Pol (2015) 0.75

Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. EuroIntervention (2016) 0.75

Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Europace (2012) 0.75

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J (2020) 0.75

Y chromosomal STR analysis using Pyrosequencing technology. Forensic Sci Int Genet (2009) 0.75

Analysis of the mitochondrial genome in sudden infant death syndrome. Acta Paediatr (2003) 0.75

Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey. Europace (2013) 0.75

Current investigation and management of patients with syncope: results of the European Heart Rhythm Association survey. Europace (2013) 0.75

[In Process Citation]. Lakartidningen (2015) 0.75

Collecting and preserving biological samples from challenging environments for DNA analysis. Biopreserv Biobank (2014) 0.75